SEOUL, South Korea, Nov. 6, 2023 /PRNewswire/ — AIRS Medical, a leader in AI-powered healthcare solutions, has announced a strategic partnership with FONAR Corporation (NASDAQ: FONR), the pioneering force in MRI technology. This collaboration aims to advance business development in North America.
AIRS Medical’s flagship product, SwiftMR™, enhances MRI image quality through advanced deep learning. SwiftMR™ can cut MRI scan times by up to 50% while improving image clarity with AI-driven denoising and sharpening. FONAR, established in 1978, launched the first commercial MRI scanner in 1980. Its current highlight, the 0.6T UPRIGHT® MRI, allows for imaging in various patient postures including sitting, standing, and bending.
Expanding Horizons with SwiftMR™
Through this partnership, AIRS Medical is extending the capabilities of SwiftMR™ to lower-field MRI scanners, opening up new market opportunities. Kevin Yang, Head of U.S. Operations & Clinical Research at AIRS Medical, stated, “We anticipate that our strategic partnership with FONAR will accelerate our growth and enhance our presence in the North American market. By leveraging FONAR’s 45 years of expertise, we expect significant improvements in our U.S. operations, from sales and marketing to research collaborations.”
Showcase at RSNA 2023
Under the theme “Breaking the Common Belief of MRI through AI,” AIRS Medical will present a range of innovative AI healthcare technologies at RSNA 2023. A significant milestone this year is the US FDA clearance for SwiftMR™ to be used on all body parts, pulse sequences, and MRI scanner models ranging from 0.25T to 3.0T.
AIRS Medical will also feature two research abstracts and host two AI Theater Presentations at RSNA. Dr. Yangsean Choi will discuss the clinical applications and ongoing research of SwiftMR™ in neuroradiology. Additionally, John Greenhalgh, Ph.D., Vice President of Research and Development at FONAR, will share his insights on implementing SwiftMR™ in FONAR’s UPRIGHT® MRI systems. Visit AIRS Medical at RSNA Booth #4552 for more information.
Published by: PRNewswire (SOURCE: AIRS Medical Inc.)
